GR58608B - Process for the production of a stable insulin preparation with protracted effect - Google Patents

Process for the production of a stable insulin preparation with protracted effect

Info

Publication number
GR58608B
GR58608B GR49734A GR760149734A GR58608B GR 58608 B GR58608 B GR 58608B GR 49734 A GR49734 A GR 49734A GR 760149734 A GR760149734 A GR 760149734A GR 58608 B GR58608 B GR 58608B
Authority
GR
Greece
Prior art keywords
production
insulin preparation
stable insulin
protracted effect
protracted
Prior art date
Application number
GR49734A
Other languages
English (en)
Inventor
B Hansen
H Andresen
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of GR58608B publication Critical patent/GR58608B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GR49734A 1975-01-15 1976-01-07 Process for the production of a stable insulin preparation with protracted effect GR58608B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (da) 1975-01-15 1975-01-15 Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.

Publications (1)

Publication Number Publication Date
GR58608B true GR58608B (en) 1977-11-10

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
GR49734A GR58608B (en) 1975-01-15 1976-01-07 Process for the production of a stable insulin preparation with protracted effect

Country Status (36)

Country Link
JP (1) JPS5946939B2 (el)
AR (1) AR213088A1 (el)
AT (1) AT362492B (el)
BE (1) BE837600A (el)
BR (1) BR7600206A (el)
CA (1) CA1094549A (el)
CH (1) CH631625A5 (el)
CS (1) CS208147B2 (el)
DD (1) DD124379A5 (el)
DE (1) DE2600971C2 (el)
DK (1) DK140801B (el)
EG (1) EG11988A (el)
ES (1) ES444558A1 (el)
FI (1) FI66751C (el)
FR (1) FR2297634A1 (el)
GB (1) GB1524431A (el)
GR (1) GR58608B (el)
HU (1) HU175142B (el)
IE (1) IE42395B1 (el)
IL (1) IL48845A (el)
IN (1) IN143279B (el)
IT (1) IT1054211B (el)
KE (1) KE2919A (el)
LU (1) LU74175A1 (el)
MX (1) MX4052E (el)
MY (1) MY7900169A (el)
NL (1) NL166464C (el)
NO (1) NO146698C (el)
NZ (1) NZ179733A (el)
OA (1) OA05209A (el)
PL (1) PL99927B1 (el)
PT (1) PT64696B (el)
RO (1) RO71576A (el)
SE (1) SE437219B (el)
YU (1) YU8376A (el)
ZA (1) ZA7658B (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (da) * 1979-09-07 1981-03-08 Nordisk Insulinlab Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
EP2504052B1 (en) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
RS64124B1 (sr) 2014-05-07 2023-05-31 Boehringer Ingelheim Int Inhalator i kontejner

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
HU175142B (hu) 1980-05-28
AU1030776A (en) 1977-07-21
IE42395B1 (en) 1980-07-30
FR2297634A1 (fr) 1976-08-13
PT64696A (fr) 1976-02-01
NO760118L (el) 1976-07-16
RO71576A (ro) 1980-12-30
BE837600A (fr) 1976-07-15
IE42395L (en) 1976-07-15
MX4052E (es) 1981-11-24
EG11988A (en) 1978-06-30
IT1054211B (it) 1981-11-10
GB1524431A (en) 1978-09-13
CH631625A5 (en) 1982-08-31
NL7600338A (nl) 1976-07-19
ZA7658B (en) 1976-12-29
AT362492B (de) 1981-05-25
NO146698C (no) 1982-11-24
PT64696B (fr) 1977-08-10
FI760058A (el) 1976-07-16
PL99927B1 (pl) 1978-08-31
CA1094549A (en) 1981-01-27
DK140801C (el) 1980-04-21
BR7600206A (pt) 1976-08-31
ATA21376A (de) 1980-10-15
YU8376A (en) 1982-06-30
NZ179733A (en) 1978-04-28
ES444558A1 (es) 1977-05-16
SE437219B (sv) 1985-02-18
NO146698B (no) 1982-08-16
JPS5946939B2 (ja) 1984-11-15
IL48845A (en) 1981-06-29
NL166464B (nl) 1981-03-16
AR213088A1 (es) 1978-12-15
NL166464C (nl) 1981-08-17
IL48845A0 (en) 1976-03-31
KE2919A (en) 1979-03-30
DK140801B (da) 1979-11-19
DE2600971A1 (de) 1976-07-22
JPS51125299A (en) 1976-11-01
LU74175A1 (el) 1977-03-18
DD124379A5 (el) 1977-02-16
DE2600971C2 (de) 1985-12-12
MY7900169A (en) 1979-12-31
FI66751C (fi) 1984-12-10
DK8375A (el) 1976-07-16
FR2297634B1 (el) 1979-03-30
SE7600284L (sv) 1976-07-16
IN143279B (el) 1977-10-29
FI66751B (fi) 1984-08-31
OA05209A (fr) 1981-02-28
CS208147B2 (en) 1981-08-31

Similar Documents

Publication Publication Date Title
GR58608B (en) Process for the production of a stable insulin preparation with protracted effect
JPS51118763A (en) Production of alkylenecarbonate
HU172453B (hu) Sposob poluchenija proizvodnykh fenil-uskusnoj kisloty
IL58864A0 (en) Process for the production of derivatives of phenylacetic acid
PT65909B (en) Process for the preparation of a symmetrical bis-carbamoylcompound with pesticidal activity
JPS5212162A (en) Production of phenylindoline
GR59280B (en) Process for the preparation of 1-aryloxy-3-n-substituted aminopropane derivatives
JPS51141897A (en) Production of riphamycin
IL47443A (en) Process for the manufacture of insulin analogs and derivatives thereof
JPS51131873A (en) Production of 44loneralkyll 55cyanoooxazole
JPS5234918A (en) Production of gmmaglobulin suitable for dosing into vein
AU1707276A (en) Process for the preparation of a phosphorodichloridothiolate
JPS5262298A (en) Production of ripaamycin compound with high antiibacterial property
JPS51115465A (en) Production of 55phenyll 22framidoxime
PT65713B (en) Process for preparation of cycloalkanapyrazole with effectherbicide
GB1520681A (en) Process for the production of phoroglucinol
GB1546177A (en) Process for the preparation of a stable injectable solution
GB1548670A (en) Pricess for the production of 2-amino-3-hydroxypyridines
JPS51138668A (en) Production of 211hydroxyy 166pregnenn200one derivatives
JPS51125379A (en) Production of aminopyrole derivatives
KE2862A (en) A process for the manufacture of benodiazepine derivatives
JPS5257173A (en) Production of thiazole
JPS5212186A (en) Production of mydecamycine derivatives
JPS5279087A (en) Production of antiiulcer substance
JPS51128997A (en) Production of pyrazolopyridineketones